Soins de la vision HOYA, leader de l'innovation en matière de technologie optique, a partagé les résultats d'une étude clinique de suivi de trois ans sur sonMiYOSMARTlentille de lunettes avec technologie brevetée Defocus Incorporated Multiple Segments (D.I.M.S.) après avoir publié l'information lors de la récente conférence de l'Académie européenne d'optométrie et d'optique (EAOO) 21Lenouvelle étude, publié enLe mois de mars 2021dans le British Journal of Ophthalmology, was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University and follows-up on the two-year study which previously demonstrated evidence of the effectiveness of the lens in slowing down the progression of myopia in children ages 8-131.

L'étude de suivi de trois ans, réalisée sur 120 enfantsAsie, included 65 from the original group using MiYOSMART lens who took part in the previous study and 55 children who moved from using a single-vision lens for two years to the MiYOSMART lens in the third yearÀ la fin de la troisième année, results in the original group of children using MiYOSMART lens showed that slowing in myopia progression over time was sustained and the group that moved from regular single-vision to MiYOSMART spectacle lens showed a significant and immediate slow-down in the progression of myopia.